This Article  • Full text  • PDF  • Reply to article  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on HighWire  • Citing articles on Web of Science (11)  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Topic Collections  • Pediatric Ophthalmology  • Retinal/ Chorioretinal Disorders  • Retinal Detachment  • Vitreoretinal Surgery  • Prognosis/ Outcomes  • Alert me on articles by topic  Social Bookmarking   What's this?

Andrew A. Moshfeghi, MD; Michael J. Banach, MD; Gohar A. Salam, MD; Philip J. Ferrone, MD

Arch Ophthalmol. 2004;122:1816-1818.

Objective  To describe the results of lens-sparing vitrectomy in infants with progressive, fovea-threatening, tractional retinal detachments associated with stage 4A retinopathy of prematurity.

Methods  In a retrospective, interventional, consecutive clinical case series, the records of patients with stage 4A retinopathy of prematurity who underwent lens-sparing vitrectomy for progressive retinal detachments were reviewed. Retinal attachment status, reversed or arrested retinal dragging, and visual acuity were assessed after the procedure.

Results  Thirty-two eyes of 29 patients underwent lens-sparing vitrectomy at a mean postconceptional age of 43 weeks. Thirty (94%) of 32 eyes had complete retinal reattachment and arrest or reversal of retinal dragging after 1 lens-sparing vitrectomy. Visual acuity of at least central, steady, and unmaintained was observed in 17 (81%) of the 21 eyes in which it was tested and at least central, steady, and maintained vision was measured in 13 (62%) of 21 eyes, with 1 eye achieving 20/40 visual acuity.

Conclusions  Lens-sparing vitrectomy is a safe and effective procedure for the treatment of fovea-threatening retinal detachments in patients with stage 4A retinopathy of prematurity.

Author Affiliations: Department of Ophthalmology, North Shore Long Island Jewish Health System, Great Neck, NY (Drs Moshfeghi, Salam, and Ferrone); Retina Consultants, Camp Hill, Pa (Dr Banach); Bascom Palmer Eye Institute, University of Miami School of Medicine, Miami, Fla (Dr Moshfeghi); and Long Island Vitreoretinal Consultants, Great Neck (Dr Ferrone).

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Efficacy of intravitreal injection of bevacizumab for severe retinopathy of prematurity: a pilot study
Kusaka et al.
Br J Ophthalmol 2008;92:1450-1455.
ABSTRACT | FULL TEXT  

Visual outcomes after 3-port lens-sparing vitrectomy in stage 4 retinopathy of prematurity.
Lakhanpal et al.
Arch Ophthalmol 2006;124:675-679.
ABSTRACT | FULL TEXT  

Lens Clarity After 3-Port Lens-Sparing Vitrectomy in Stage 4A and 4B Retinal Detachments Secondary to Retinopathy of Prematurity
Lakhanpal et al.
Arch Ophthalmol 2006;124:20-23.
ABSTRACT | FULL TEXT